BBHC
AMRI

Brown Brothers Harriman & Co’s Albany Molecular Research Inc AMRI Stock Holding History

Brown Brothers Harriman & Co’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-150
Closed -$3K – 832
2015
Q3 		$3K Sell
150
-150
-50% -$3.05K ﹤0.01% 774
2015
Q2 		$6K Buy
+300
New +$5.79K ﹤0.01% 677

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Brothers Harriman & Co's AMRI Position: Q4 2015 in Review

Brown Brothers Harriman & Co sold out of Albany Molecular Research Inc (AMRI) in Q4 2015, closing a stake of 150 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in AMRI in Q2 2015 and held it in 2 quarters. The position peaked at $6K in Q2 2015. 151 funds tracked by Wall St. Rank hold AMRI as of Q4 2015.

  • Brown Brothers Harriman & Co reported no remaining Albany Molecular Research Inc position as of Q4 2015 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 150 Albany Molecular Research Inc shares in Q4 2015, an estimated $3K.
  • Brown Brothers Harriman & Co first reported a position in Albany Molecular Research Inc in Q2 2015 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Albany Molecular Research Inc position peaked at $6K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2015.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2015, filed 12 Feb 2016.